WHO Prepares To Deploy Experimental Ebola Vaccine To Congo In Latest Outbreak

Associated Press: Ebola vaccines to be shipped to Congo, WHO chief says
“Ebola vaccines will be shipped as quickly as possible to Congo as the number of suspected cases in the latest outbreak grows, the head of the World Health Organization said Friday as the agency prepared for a ‘worst-case scenario’…” (Mwanamilongo/Keaten, 5/11).

Reuters: WHO has 4,000 Ebola vaccines ready for Congo deployment
“… ‘We’re working on the deployment of these materials, especially readying the cold chain,’ WHO Africa Director Matshidiso Moeti told Reuters by telephone. ‘The start date of the vaccinations will depend on this deployment’…” (Ligodi/Cox, 5/13).

STAT: WHO readies to test Merck’s experimental Ebola vaccine in Congo outbreak
“…There are currently 4,300 doses of Merck’s V920 vaccine in Geneva, held by the WHO, the company told STAT in an email. Merck has given its permission for that stock to be used in DRC…” (Branswell, 5/11).

Additional coverage of this story is available from New York Times, Reuters, STAT, and Washington Post.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.